BONSITY: The new name for Alvogen’s Teriparatide Injection 620 mcg/2.48 mL; same affordable alternative to FORTEO® (teriparatide injection)

request a representative

Get in touch with a BONSITY representative

Fill out the form below to get more information on how BONSITY can help keep your patients moving.

All fields are required.

For questions regarding BONSITY, including insurance coverage:


For medical questions or to report adverse events:


Access and affordability

79% of Medicare Part D lives have access to BONSITY.1

Explore coverage and savings

Proven efficacy and safety

BONSITY builds on more than 20 years of clinical experience.

See the data

Reference:

  1. Data on file. Alvogen, Inc.